ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,344.81
1.08%
S&P 500
5,460.48
-0.41%
Dow Jones
39,118.86
-0.12%
US Dollar vs Yen
161.025
0.07%
Brent Oil
85.325
0.25%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/0114 : 33PR Newswire (US)Global Times: CPC members reach 99.185 million
2024/07/0114 : 31GlobeNewswire Inc.Kalmar’s financial information in 2024
2024/07/0114 : 30Alliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:INHCInduction Healthcare Group Plc
2024/07/0114 : 30Alliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:PRVPorvair Plc
2024/07/0114 : 30Alliance NewsAlliance NewsAlliance News UK - start of day
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ LSE:0RADOse Immunotherapeutics Sa
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’LSE:0RADOse Immunotherapeutics Sa
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’TG:6OPOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ TG:6OPOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
2024/07/0114 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
2024/07/0114 : 30GlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024TG:FRUMultitude SE
2024/07/0114 : 30GlobeNewswire Inc.Kalmar specifies its outlook for 2024
2024/07/0114 : 30GlobeNewswire Inc.Sampo plc’s share buybacks 28 June 2024
2024/07/0114 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
2024/07/0114 : 30GlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024XE:FRUMultitude SE
2024/07/0114 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
2024/07/0114 : 30GlobeNewswire Inc.Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purchase all of the outstanding common shares and SDRs of Millicom International Cellular S.A. for USD 24.00 in cash per Common Share and per SDR
2024/07/0114 : 30PR Newswire (US)XRP Healthcare: Helping to Transform HIV and AIDS Care with Innovative Prescription Savings Solutions
2024/07/0114 : 30PR Newswire (US)XRP Healthcare: Helping to Transform HIV and AIDS Care with Innovative Prescription Savings Solutions
2024/07/0114 : 18Business WireBW LPG Limited - Successful Completion of the Redomiciliation to SingaporeNYSE:BWLPBW LPG Limited
2024/07/0114 : 08PR Newswire (Canada)WestJet confirms end to AMFA strike
2024/07/0114 : 07PR Newswire (Canada)KEENON Robotics a fait une présentation intitulée « Where Humans Meet Machines » lors de la Réunion annuelle 2024 des nouveaux champions du Forum économique mondial, à Dalian : Les robots permettent à l'IA d'entrer dans le monde physique
2024/07/0114 : 05Business WireHAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award
2024/07/0114 : 04CointelegraphNFT sales fell 44% as crypto dipped, memecoins steal ‘mind share’ in Q2COIN:PEPEUSDPepe
2024/07/0114 : 03Alliance NewsAlliance NewsTOP NEWS: Japan's manufacturing sector unexpectedly stalls in June
2024/07/0114 : 01Alliance NewsAlliance NewsTOP NEWS: China's manufacturing sector hits highest level since 2021

最近閲覧した銘柄

COIN
GENEBTC
LSE
ZU16
Qnb Fin 23
USOTC
AXFOF
Axfood AB (PK)
TG
SKNB
Skanska AB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有